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Palliative care: Earlier is better
For patients with metastatic cancer, early palliative 
care—with a referral at diagnosis—has many benefi ts. 
PRACTICE CHANGER 
Recommend a palliative care consultation at 
the time of diagnosis. Early palliative care can 
improve quality of life, decrease depressive 
symptoms, and prolong life in patients with 
metastatic cancer.1 
STRENGTH OF RECOMMENDATION
B: Based on a single well-done randomized 
controlled trial (RCT). 
Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for pa-
tients with metastatic non–small-cell lung cancer. N Engl J Med. 
2010;363:733-742.
ILLUSTRATIVE CASE 
A 73-year-old patient you’ve known for your 
entire career comes in for follow-up after a 
recent hospitalization, during which he was 
diagnosed with metastatic non–small-cell lung 
cancer. “I know things don’t look good,” he 
says. “I don’t want to die a miserable, painful 
death. But I’m not going to just roll over and 
die without fi ghting this.” What can you do to 
improve his quality of life while he undergoes 
cancer treatment?
Palliative care focuses on the prevention and treatment of pain and other de-bilitating eff ects of serious illness, with 
a goal of improving quality of life for patients 
and their families. Unlike hospice care, which 
requires a prognosis of less than 6 months of 
life to qualify for Medicare reimbursement,2 
eligibility for palliative care is not dependent 
on prognosis. Indeed, palliative care can 
occur at the same time as curative or life-
prolonging treatment. Palliative care pro-
grams include psychosocial and spiritual care 
for patient and family; management of symp-
toms such as pain, fatigue, shortness of breath, 
depression, constipation, and nausea; support 
for complex decisions, such as discussions of 
goals, do not resuscitate (DNR) orders, and re-
quests for treatment; and coordination of care 
across various health care settings.3 
Palliative care lowers 
health care spending 
One study found that palliative care consulta-
tion was associated with an average savings 
of $1700 per admission for patients who were 
discharged, and $4900, on average, for every 
patient who died in the hospital.4 Another 
study demonstrated an association between 
states with a higher percentage of hospitals 
with palliative care services and fewer Medi-
care hospital deaths; fewer admissions to, 
and days in, intensive care units in the last 
6 months of life; and lower total Medicare 
spending per enrollee.5 
A 2008 systematic review of the eff ective-
ness of palliative care revealed that there were 
methodological limitations in all the existing 
studies of palliative care, and called for higher 
quality studies.6 Th e RCT detailed here is a fi rst 
step toward fi lling the gap in palliative care 
research.
STUDY SUMMARY
Intervention group lived longer 
and felt better
Temel et al enrolled 151 ambulatory patients 
with biopsy-proven non–small-cell lung cancer. 
Th e average age of the enrollees was 64 years, 
and slightly more than half (51.6%) were female. 
All had been diagnosed with metastatic cancer 
within 8 weeks of enrollment in the study.
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Th e patients were randomized to receive 
either an early referral to the palliative care 
team along with standard oncology care or 
standard oncology care alone. Race, mari-
tal status, smoking history, presence of brain 
metastases, and initial cancer therapy—radia-
tion, chemotherapy, or a combination—were 
similar for both groups.
Th e study ran for 12 weeks. Th ose in the 
intervention group had an initial meeting 
with a member of the palliative care team, 
which consisted of board-certifi ed pallia-
tive care physicians and advanced practice 
nurses. Follow-up meetings with the team 
were scheduled at least monthly, and more 
frequently if requested by the patient or rec-
ommended by either the palliative care team 
or the oncology team—with an average of 
4 meetings over the course of the study. Pallia-
tive care team members worked with patients 
to assess physical and emotional symptoms, 
coordinate care, and determine and docu-
ment goals of treatment. 
❚ The primary outcome was the change 
in quality of life (QOL) from baseline to 
12 weeks after the initial meeting with the 
palliative care team. QOL was measured with 
the Functional Assessment of Cancer Th era-
py-Lung (FACT-L) tool; scores range from 0 
to 136, with higher scores indicating a higher 
QOL. Th e researchers used 3 subscales of 
the FACT-L—physical well-being, functional 
well-being, and a lung-cancer subscale (LCS) 
based on questions about 7 symptoms—to 
create a Trial Outcome Index (TOI), the main 
outcome measure. Th e TOI, which is the sum 
of the subscales, has a range of 0 to 84, with 
higher scores indicating higher QOL. 
❚ Secondary outcome measures were 
mood, use of health care services, and 
survival. Th e researchers assessed mood 
with 2 tools: the Patient Health Question-
naire-9 (PHQ-9) and the Hospital Anxiety 
and Depression Scale (HADS). Th e PHQ-9 
is a 9-question survey that uses criteria from 
the Diagnostic and Statistical Manual of 
Psychiatric Disorders, 4th edition (DSM-IV) 
to diagnose depression. HADS is a 14-ques-
tion survey with subscales for depression 
(HADS-D) and anxiety (HADS-A). 
❚ Intervention group had better scores.
At study’s end, the control group had av-
erage scores of 91.5, 19.3, and 53.0 on the 
FACT-L, LCS, and TOI, respectively, vs 98.0, 
21.0, and 59.0 for the intervention group. 
Th e palliative care group had an average in-
crease on the TOI of 2.3 points, while the 
average for the control group decreased 
by 2.3 points (P=.04). A comparison of 
the mean change in scores between the 
2 groups indicated statistically signifi cant im-
provements in the FACT-L and TOI results for 
the intervention group. Th e improvement in 
LCS was not statistically signifi cant. 
Th e palliative care group also had a lower 
prevalence of depression compared with the 
controls (4% vs 17% on the PHQ-9 [P=.04]; 
16% vs 38% on the HADS-D [P=.01]). For every 
8 patients who received early palliative care, 1 
less patient was diagnosed with depression. 
Th e prevalence of anxiety was not signifi cantly 
diff erent between groups. 
Among patients who died during the 
study period, those in the palliative care group 
were less likely to have received aggressive 
end-of-life interventions compared with the 
controls (33% vs 54%, respectively, P=.05). Ag-
gressive care was defi ned as chemotherapy 
within 14 days of death or little or no hospice 
care. Th ose in the early palliative care group 
also lived signifi cantly longer; median sur-
vival was 11.6 months, vs 8.9 months for the 
control group (P=.02). 
WHAT’S NEW
This study highlights 
the need for early referral
Th is is the fi rst high-quality RCT to demon-
strate improved patient outcomes when pal-
liative care is begun close to the time of cancer 
diagnosis. Previous studies of late palliative 
care referrals did not demonstrate improved 
QOL or more appropriate use of health care 
services. Th is study established that patients 
with lung cancer are less depressed and live 
longer when they receive palliative care ser-
vices soon after diagnosis. It also showed a 
link between palliative care and a reduction in 
aggressive, possibly inappropriate, end-of-life 
treatment of metastatic cancer.
Several recent practice guidelines, in-
cluding that of the Institute for Clinical Sys-
tems Improvement (ICSI), recommend that 
Do you recommend 
palliative care to 
patients with meta-
static cancer at the 
time of diagnosis? 
■  Yes, I do so routinely. 
■  Often 
■  Rarely or never
■ Other _____________
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Despite receiving 
less aggressive 
care, patients 
in the 
intervention 
group lived 
longer.
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palliative care referrals be made early in the 
course of a progressive, debilitating illness, 
regardless of the patient’s life expectancy.7
Other organizations, including the Institute 
of Medicine and the World Health Orga-
nization, recommend palliative care as an 
essential component of comprehensive can-
cer care.8 Th is study supports both of these 
recommendations. 
CAVEATS 
Would extra attention from
any clinician work equally well?
No attempt was made to control for the extra 
attention (an average of 4 visits) that the pal-
liative care team provided to those in the in-
tervention group. Th us, it is possible that the 
study results could be replicated by having 
patients meet with their primary care physi-
cian or another health professional instead of 
a palliative care team. 
Th e reduction in depression and increase 
in survival are clinically signifi cant outcomes. 
But the improvement in QOL (an average of 
7 points better on the 136-point FACT-L scale, or 
6 points on the 84-point TOI scale) may not be. 
It is important to note, too, that the sur-
vival benefi ts the researchers found may not 
be generalizable to other kinds of cancers. In 
addition, most patients (97%) in this study 
were white, so the fi ndings may be less gen-
eralizable to patients of other races. Nonethe-
less, we think it’s likely that the improvements 
in QOL and mood revealed in this study would 
be realized by most patients with terminal 
cancer who received early palliative care.
CHALLENGES TO IMPLEMENTATION
Palliative care must be explained—
and available 
Physicians must be able to explain to their pa-
tients the diff erence between palliative care 
and hospice—most notably, that patients 
can continue to receive anticancer treatment 
while receiving palliative care. Th e recom-
mendation to seek palliative care should not 
be considered “giving up” on the patient.
In order to refer patients to palliative care 
early in the course of cancer care, physicians 
must have access to a palliative care team, 
which may not be available in all cases. In 
2006, only 53% of hospitals with more than 
50 beds reported having a palliative care pro-
gram.5 If there is no such program available, 
physicians can refer to the ICSI guideline on 
palliative care for more information on how to 
implement elements of palliative care for their 
patients with advanced cancer.7  JFP
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